No menu items!
Tuesday, November 5, 2024

New Delhi-based National Institute of Immunology (NII)

DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9

ASPAGNIITM is being used in dendritic cell (DC) based immunotherapy in cervical, ovarian cancer and will also be used in breast cancer. ASPAGNIITM may revolutionise cancer treatment Cancer kills 8.51 lakh people in India every year (International Agency for Research on...
- Advertisement -spot_img

Latest News

GeM Partnership with Sikkim: Boosting Digital Procurement Across India

The Indian government’s public procurement portal, Government e-Marketplace (GeM), has recently signed a landmark agreement with the Sikkim government....
- Advertisement -spot_img